Formulation of a modern anti-human glioma drug from nanoparticles
green-synthesized using Ocimum basilicum: A pre-clinical trial study
Abstract
This research showed that the iron nanoparticles (FeNPs) formulated with
Ocimum basilicum aqueous extract having potent antioxidant and
anti-human glioma activities in vitro condition. For determinate the
properties of the FeNPs that were produced from the reaction between
iron chloride solution with aqueous Ocimum basilicum extract, we used
UV–Visible Spectroscopy (UV-Vis), Field Emission Scanning Electron
Microscopy (FE‐SEM), and Fourier Transformed Infrared Spectroscopy
(FT‐IR). To survey the cytotoxicity and anti-human glioma effects of
FeNPs, MTT assay was used on the SW1088, LN-229, U-87 and A-172 cell
lines. For investigating the antioxidant properties of FeNPs, the DPPH
test was used in the presence of butylated hydroxytoluene as the
positive control. Iron nanoparticles had very low cell viability and
anti-human glioma properties dose-dependently against SW1088, LN-229,
U-87 and A-172 cell lines without any cytotoxicity on the normal cell
line. The IC50 of the iron nanoparticles were 101, 75, 97, and 54 µg/ml
against SW1088, LN-229, U-87 and A-172 cell lines. DPPH test revealed
similar antioxidant potentials for FeNPs and butylated hydroxytoluene.
It seems that the anti-human glioma effects of recent nanoparticles is
due to their antioxidant properties.